Literature DB >> 23538645

Cronobacter: an emerging opportunistic pathogen associated with neonatal meningitis, sepsis and necrotizing enterocolitis.

C J Hunter1, J F Bean.   

Abstract

Members of the genus Cronobacter are an emerging group of opportunist Gram-negative pathogens. This genus was previously thought to be a single species, called Enterobacter sakazakii. Cronobacter spp. typically affect low-birth-weight neonates, causing life-threatening meningitis, sepsis and necrotizing enterocolitis. Outbreaks of disease have been associated with contaminated infant formula, although the primary environmental source remains elusive. Advanced understanding of these bacteria and better classification has been obtained by improved detection techniques and genomic analysis. Research has begun to characterize the virulence factors and pathogenic potential of Cronobacter. Investigations into sterilization techniques and protocols for minimizing the risk of contamination have been reviewed at national and international forums. In this review, we explore the clinical impact of Cronobacter neonatal and pediatric infections, discuss virulence and pathogenesis, and review prevention and treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23538645     DOI: 10.1038/jp.2013.26

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  40 in total

1.  Profiling of the viable bacterial and fungal microbiota in fermented feeds using single-molecule real-time sequencing.

Authors:  Jie Yu; Qiangchuan Hou; Weicheng Li; Weiqiang Huang; Lanxin Mo; Caiqing Yao; Xiaona An; Zhihong Sun; Hong Wei
Journal:  J Anim Sci       Date:  2020-02-01       Impact factor: 3.159

2.  Identification and Characterization of Cronobacter Strains Isolated from Environmental Samples.

Authors:  Jinrui Hu; Xiaofang Li; Xiaoli Du; Zhigang Cui; Jinghua Cui
Journal:  Curr Microbiol       Date:  2019-10-04       Impact factor: 2.188

3.  Rho kinase inhibition maintains intestinal and vascular barrier function by upregulation of occludin in experimental necrotizing enterocolitis.

Authors:  Justyna S Grothaus; Guillermo Ares; Carrie Yuan; Douglas R Wood; Catherine J Hunter
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-06-21       Impact factor: 4.052

4.  Adherence inhibition of Cronobacter sakazakii to intestinal epithelial cells by lactoferrin.

Authors:  Maria I Quintero-Villegas; Anja Wittke; Robert Hutkins
Journal:  Curr Microbiol       Date:  2014-06-14       Impact factor: 2.188

Review 5.  Early-onset neonatal sepsis.

Authors:  Kari A Simonsen; Ann L Anderson-Berry; Shirley F Delair; H Dele Davies
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

Review 6.  The impact of the milk glycobiome on the neonate gut microbiota.

Authors:  Alline R Pacheco; Daniela Barile; Mark A Underwood; David A Mills
Journal:  Annu Rev Anim Biosci       Date:  2014-11-05       Impact factor: 8.923

7.  Lactobacillus spp. inhibit the growth of Cronobacter sakazakii ATCC 29544 by altering its membrane integrity.

Authors:  Raffaella Campana; Sara Federici; Eleonora Ciandrini; Anita Manti; Wally Baffone
Journal:  J Food Sci Technol       Date:  2019-07-11       Impact factor: 2.701

8.  Is Cronobacter sakazakii infection possible in an exclusively breastfed premature neonate in the neonatal intensive care unit?

Authors:  S Ravisankar; S S Syed; P Garg; J Higginson
Journal:  J Perinatol       Date:  2014-05       Impact factor: 2.521

9.  Comparative Genotypic and Phenotypic Analysis of Cronobacter Species Cultured from Four Powdered Infant Formula Production Facilities: Indication of Pathoadaptation along the Food Chain.

Authors:  Qiongqiong Yan; Juan Wang; Jayanthi Gangiredla; Yu Cao; Marta Martins; Gopal R Gopinath; Roger Stephan; Keith Lampel; Ben D Tall; Séamus Fanning
Journal:  Appl Environ Microbiol       Date:  2015-04-24       Impact factor: 4.792

Review 10.  Pathophysiology and current management of necrotizing enterocolitis.

Authors:  Himabindu Kasivajjula; Akhil Maheshwari
Journal:  Indian J Pediatr       Date:  2014-03-22       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.